Form EFFECT Immuneering Corp
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 8, 2025 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho defends Immuneering Corporation (IMRX), 'recommend being opportunistic on IMRX'
- Insilica CEO Co-Authors New Framework to Standardize High-Stakes AI in Toxicology
- HelloNation Highlights Deep Cleaning for Gum Disease Prevention With Dental Expert Dr. John Morgan Jackson III, D.M.D.
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
